Catheter ablation for atrial fibrillation with low-voltage mapping
Part of Heart & circulation clinical trials.
This trial studies a catheter procedure that targets areas in the heart that show low electrical voltage to treat atrial fibrillation (an irregular heartbeat). You may be eligible if you have non-paroxysmal atrial fibrillation, have tried heart rhythm medicines, and your scan shows low-voltage areas in the left atrium.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have non-paroxysmal atrial fibrillation (it doesn’t come and go on its own).
- You have tried at least one antiarrhythmia medicine and it didn’t work or you couldn’t tolerate it.
- You are between 18 and 85 years old when you sign consent.
- Your doctor has already scheduled an atrial fibrillation ablation for you.
- During the procedure, a special 3-D heart map shows low-voltage areas in the left atrium.
- You can follow study visits and you sign the informed consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies catheter ablation, a procedure that targets heart rhythm triggers, for people with atrial fibrillation (an irregular heartbeat). It may help improve rhythm control, but you must meet specific heart and testing requirements and avoid certain conditions.
This trial tests whether using a special heart-mapping device during ablation (a procedure to fix irregular heartbeats) can improve outcomes for people with persistent atrial fibrillation and an enlarged left heart chamber.
This study tests a heart rhythm procedure that uses electrical mapping to guide ablation (controlled scarring) of a specific area in the heart's left upper chamber to treat persistent atrial fibrillation—a condition where the heart beats irregularly for more than a week at a time. The goal is to see if this targeted approach helps restore normal heart rhythm.
This study tests a way to perform catheter ablation for atrial fibrillation using a non-fluoroscopic lab, meaning no x-ray is needed during the procedure. It may help patients avoid radiation exposure.
This study tests a new ablation method for people with atrial fibrillation who have not had a prior episode and whose heart tissue shows no low-voltage areas but has a transition zone during mapping. It aims to see if targeting this area improves outcomes.
This trial tests a catheter ablation procedure for people with persistent atrial fibrillation (a type of irregular heartbeat that lasts more than 7 days but less than a year). It aims to see if the procedure is safe and effective for restoring a normal heart rhythm.
Hear when a new Atrial Fibrillation - Symptomatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.